BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2003
View Archived Issues
FluINsure shows positive results in influenza challenge study
Read More
Twice-daily schedule suggested for fampridine-SR in patients with chronic SCI
Read More
Astex achieves milestone in Alzheimer's drug discovery collaboration
Read More
CAT and Genzyme strengthen drug development collaboration
Read More
DepoMed acquires exclusive rights to novel gabapentin formulation
Read More
Phase IIa study initiated with SPI-8811 for cystic fibrosis
Read More
Alnylam enters RNAi-based therapy collaboration with Stanford University
Read More
Pivotal trial for Hunter's syndrome begins dosing
Read More
New formulation of Singulair available for young children with asthma
Read More
FDA grants satraplatin fast track designation
Read More
New antiangiogenic agents and their use patented by EntreMed
Read More
Takeda presents new GnRH antagonists for cancer, prostatic hypertrophy, etc.
Read More
Dainippon scientists prepare and test novel glucagon antagonists
Read More
New antifungal agents in early development at Daiichi
Read More
Novel agents for urinary incontinence described by Mochida and Asahi Glass
Read More
New CDK inhibitors in BMS development pipeline
Read More
Phase IIIa study of Neutralase halted
Read More
FDA accepts filing for DepoMorphine
Read More
Lumiracoxib approved by the MHRA for osteoarthritis and other indications
Read More
New CCR3 antagonist with oral activity in animal model of atopic dermatitis
Read More
3DP presents new orally active thrombin inhibitors at ACS meeting
Read More
Development of potent, selective cPLA2alpha inhibitors as antiinflammatory/analgesic agents
Read More
BMS discovers selective, orally active TACE inhibitors with antiinflammatory activity
Read More
RPR-749 is safe and lowers FFA levels in first human trial
Read More
Influenza virus neuraminidase inhibitor R-118958 and its active metabolite characterized by Sankyo
Read More
Good safety and PK profile emerges for CC-8490 in healthy volunteers
Read More
Tolvaptan preserves renal function in patients with congestive heart failure
Read More